Chronic Lymphocytic Leukemia — An Interview with Prof Constantine Tam on Key Presentations from the 2025 ASH Annual Meeting
Oncology Today with Dr Neil Love
00:00
Pirtobrutinib trial results and interpretation
Tam summarizes pirtobrutinib data versus BR and ibrutinib, noting tolerability, compliance, and mixed efficacy signals.
Play episode from 30:21
Transcript
